AfterRaise daily
31 companies raised $1.6B in disclosed rounds of $5M or more. Every figure links to its source, and every company page follows what happens next.
The announcement did not set out what the funding supports.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports expand capabilities and further research efforts.
The company said the funding supports the continued clinical advancement of linsitinib, an oral small molecule inhibitor of IGF-1R (insulin-like growth factor 1 receptor), a validated target for the treatment of TED.
The company said the funding supports further enhance its proprietary AI and technology development and expand its platform capabilities.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports expand operations and its R&D efforts Led by CEO David J.
The company said the funding supports expand its engineering and consulting organization, and further enhance the development of its platform, infrastructure, and agentic skills library.
The company said the funding supports portfolio expansion, volume scale-up, product tapeouts, qualification, and engineering hiring at both company sites.
The company said the funding supports expand its resolution layer to support additional processes across operations, finance, and customer service, and grow its product, engineering, and go-to-market teams.
The company said the funding supports enable frontier research into self-improving AI for physical operations, prove its technology in the field, and expand its research and engineering team.
The company said the funding supports expand its pipeline of power partnerships and compute customers.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports launch new financing products.
The company said the funding supports validate its technology and scale its team to build customized 3D SRAM memory chips for initial datacenter customers.
The company said the funding supports accelerate product development and deepen relationships with American institutions.
The company said the funding supports roll out its second-generation platform, Mithrl-1, layered on its biomedical world model and paired with an agentic harness for model routing, token optimization, and context orchestration.
The company said the funding supports expand into additional corridors, continue acquiring local operators, and pursue a bank acquisition within the next six months.
The company said the funding supports accelerate product innovation, AI capabilities, and international expansion across Europe and Asia.
The company said the funding supports advance its proprietary care model, deepen data-driven personalization for patient engagement, enrollment, and care delivery, and expand into adjacent complex therapeutic areas, starting with autoimmune conditions.
The company said the funding supports expand its default intelligence layer for the global ETF market and scale it from EMEA to two AMER and APAC.
The company said the funding supports expand its New York City team across engineering, sales, and customer success as it builds the technology infrastructure for the $100 billion restoration industry.
The company said the funding supports support its commercial expansion and go-to-market efforts, as well as to scale its team and continue investing in engineering and product development.
The company said the funding supports fuel product development, data science, market expansion, scale its Nix Health licensable algorithm, and explore additional sweat-detectable biomarkers such as lactate, cortisol, glucose, Vitamin D, testosterone, and estrogen.
The company said the funding supports expand the platform's capabilities ad its go-to-market efforts.
The company said the funding supports expand its team and introduce new AI capabilities for strategic trade planning and compliance.
The company said the funding supports expand its engineering team, accelerate product development and bring its platform to more organisations across AI infrastructure, quantitative finance, life sciences, research and high performance computing.
The company said the funding supports expand the product, grow the team, and bring Aristotle to general availability.
The company said the funding supports accelerate the engineering development of its core chip-verification platform, fund expanding enterprise deployments, and grow its specialized semiconductor and AI research engineering teams across the United States, India, and Israel.
The company said the funding supports fund AI development across its five workflow clouds, deepen its care operations and patient outreach products, and expand the go-to-market team.
The company said the funding supports expand its laboratory network, continue to develop its AI health copilot and wearable integrations, and expand its services into the Nordics, Italy, and Portugal.
The Daily Brief
Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.